Physician profile
John D Bry
NPI 1972614238
$1,707.33
in general payments reported to CMS, 2019-2025
5 companies · $21.58 in 2025
The $21.58 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $15.81 · 2023: $1,441 · 2024: $81.82 · 2025: $21.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $963 · Food and Beverage: $554 · Education: $27.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $963.25 |
| Food and Beverage | $553.52 |
| Education | $27.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,464.51 | 2023-2024 | Ellipsys Vascular Access System, Venaseal |
| Boston Scientific Corporation | $179.65 | 2019-2023 | Eluvia |
| Bard Peripheral Vascular, INC. | $25.78 | 2019 | |
| Glaxosmithkline, LLC. | $21.58 | 2025 | Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $15.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.